Assessment of Cardiac Involvement of Common Cold in High Performing Athletes by Cardiac Magnetic Resonance Imaging (MRI)
Left Ventricular Dilatation in Athletes With Common Colds; a Cardio-vascular MRI Study
1 other identifier
observational
100
1 country
1
Brief Summary
Cardiovascular magnetic resonance (CMR) imaging will be used to assess the impact of common colds and physical training in high-performing athletes. Healthy individuals from the general public will serve as a comparison group. CMR has previously been shown to accurately assess cardiac function, edema, inflammation, and injury. Athletes competing at National level and Developmental Canadian teams will be prospectively recruited. All participants will have CMR scans at low and high intensity training. Participants will be re-scanned immediately after clinical evidence of a common cold, as determined by respiratory and flu-like symptoms. After 4 weeks, a follow-up CMR scan will be performed. On the day of each CMR scan, electrocardiograms and blood samples will be drawn from each participant. Blood samples will provide markers of systemic inflammation, such as leukocyte counts. At each CMR scan, athletes will be asked to describe there recent history of physical exertion in questionnaires, which will reflect the degree of physical exertion performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 20, 2008
CompletedFirst Posted
Study publicly available on registry
August 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedOctober 4, 2011
October 1, 2011
4.3 years
August 20, 2008
October 2, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Left-ventricular systolic dysfunction, as defined by increased left ventricular end-diastolic volume
12 months
Secondary Outcomes (1)
Myocardial edema, fibrosis, inflammation, volumetry
12 months
Study Arms (1)
Athletes
high performing athletes
Interventions
Eligibility Criteria
high performance athletes, during acute viremia and at variable training intensities. Healthy individuals from the general public will serve as a reference group.
You may qualify if:
- Informed consent;
- feverish feeling with last 72 hours;
- active participation in competitive sports;
- history of recent viral exposure or flu-like symptoms.
You may not qualify if:
- CMR Contraindications,
- chronic diseases affecting the heart,
- use of immuno-active drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stephenson CMR Centre at Foothills Medical Centre, University of Calgary
Calgary, Alberta, T2N 2T9, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias G Friedrich, MD, FESC
University of Calgary
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- adunct Research Associate Professor
Study Record Dates
First Submitted
August 20, 2008
First Posted
August 22, 2008
Study Start
June 1, 2007
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
October 4, 2011
Record last verified: 2011-10